17-year-old Dubai student builds CareCheck AI for breast cancer awareness

Saiyette Aima, a 17-year-old Dubai College student, has built CareCheck, a proposed AI breast-health platform shaped by her grandmother’s death from Stage 3 breast cancer in 2020, according to The Times of India.

The story matters in the UAE because the first commercial demand for breast-health AI is unlikely to be diagnosis. It is likely to be navigation. Clinics need safer intake pathways. Insurers need cleaner referral data. Patients need to know when a symptom, family history or abnormal change should move them to a licensed breast clinic under the Dubai Health Authority (DHA), the Department of Health Abu Dhabi (DOH) or the Ministry of Health and Prevention (MOHAP).

What CareCheck is meant to do

Aima began advocacy after losing her grandmother, who lived in Delhi, after a cancer diagnosis that followed a small mark on the neck. She later donated hair through Friends of Cancer Patients and launched For Her, For Hope on YallaGive. The campaign raised more than AED 10,400 against an initial AED 5,000 target, according to the fundraiser page and local reporting.

Her work then moved into screening and education. In India, she helped organise awareness and screening activity with doctors from AIIMS New Delhi and the National Cancer Institute in Jhajjar. More than 150 women attended, according to the Times of India report. CareCheck is the technology extension of that work: local-language guidance, breast self-awareness prompts, symptom history, reminders and directions to professional care.

"CareCheck does not diagnose cancer and it does not replace a doctor," Saiyette Aima said, according to The Times of India.

That distinction is material for UAE operators. A patient education tool has one risk profile. A clinical decision-support tool has another. A diagnostic AI product would need more evidence, governance and regulator engagement before use in a licensed care pathway.

The UAE operator question

For Dubai clinics, the relevant regulator is DHA. DHA circulated its Policy for Use of Artificial Intelligence in Healthcare Services on 22 August 2021 to DHA-licensed professionals and facilities. In Abu Dhabi and Al Ain, DOH has its own AI policy expectations, including certification, auditable validation statements and data-governance controls. In Sharjah, Ajman, Ras Al Khaimah, Fujairah and Umm Al Quwain, MOHAP is the operating regulator for licensed providers.

The immediate due-diligence checklist is short and operational:

• Clinical safety: who reviews breast-health content, how often it is updated, and what symptoms trigger urgent referral.
• Regulatory scope: whether the tool is education, triage, clinical decision support or software as a medical device.
• Data handling: where symptom history is stored, who can access it, and how consent is captured.
• Referral routing: whether users are directed to DHA, DOH or MOHAP-licensed oncology, breast surgery, radiology or primary-care providers.

For insurers such as Daman, Thiqa and Sukoon, the use case is pre-authorisation quality and earlier case finding, rather than claims reduction on day one. A tool that sends low-risk users to education and high-risk users to licensed assessment could reduce avoidable specialist visits. It could also increase mammography volume if outreach reaches women who delayed screening.

What patients and clinics can act on now

Screening rules vary by emirate and risk profile. DOH preventive-care requirements include mammography for women aged 40 to 69 every two years. MOHAP breast cancer screening guidance defines eligible screening cases as women aged 40 to 69. For Dubai, clinics should check current DHA clinical guidance and facility licensing requirements before advertising any AI-supported breast-health service.

Private-sector pricing gives clinics and payers a working benchmark. Published UAE provider pages show mammogram offers from around AED 300 to AED 1,200, depending on whether consultation, breast ultrasound or 3D imaging is included. The UAE Open Healthcare Directory lists Dubai mammogram costs at a typical AED 600 range and says its listings are sourced from official licensing data.

The commercial opening is clear. Breast-health AI that stays inside education, symptom documentation and licensed-provider navigation can be useful before it becomes a regulated diagnostic product. The governance burden is also clear. Clinics should treat any public-facing AI output as medical communication, record who approved it, and map every referral to a licensed provider. Patients looking for oncology, breast surgery or imaging services should start with the UAE Open Healthcare Directory for licensed oncology providers across Dubai, Abu Dhabi, Al Ain and the northern emirates.